Jiangsu Lanfeng Bio-chemical Co.,Ltd

Shenzhen Stock Exchange 002513.SZ

Jiangsu Lanfeng Bio-chemical Co.,Ltd EBIT for the year ending December 31, 2023: USD -45.88 M

Jiangsu Lanfeng Bio-chemical Co.,Ltd EBIT is USD -45.88 M for the year ending December 31, 2023, a -36.47% change year over year. EBIT means earnings before interest and taxes, it is calculated as operating income plus non-operating income.

Jiangsu Lanfeng Bio-chemical Co.,Ltd EBIT for the year ending December 31, 2022 was USD -33.62 M, a 58.26% change year over year.
Jiangsu Lanfeng Bio-chemical Co.,Ltd EBIT for the year ending December 31, 2021 was USD -80.54 M, a -1,585.28% change year over year.
Jiangsu Lanfeng Bio-chemical Co.,Ltd EBIT for the year ending December 31, 2020 was USD 5.42 M, a 107.50% change year over year.
Jiangsu Lanfeng Bio-chemical Co.,Ltd EBIT for the year ending December 31, 2019 was USD -72.33 M, a 42.06% change year over year.

Key data

Date	EBIT	EBITDA	Net Income	EPS (Diluted)

Shenzhen Stock Exchange: 002513.SZ

Jiangsu Lanfeng Bio-chemical Co.,Ltd

CEO	Mr. Jun Xing
IPO Date	Dec. 3, 2010
Location	China
Headquarters	No. 1 Suhua Road
Employees	1,573
Sector	Health Care
Industries Pharmaceuticals Chemicals & Advanced Materials

Description

Jiangsu Lanfeng Bio-chemical Co.,Ltd researches, develops, produces, and sells pesticides, fungicides, insecticides, herbicides, and fine chemical intermediates in China and internationally. It offers thiophanate-methyl, cyclohexazone, benomyl, and carbendazim. The company is based in Xinyi, China.

Key trends

Past 5 years